Thiogenesis Therapeutics
Toronto
About Thiogenesis Therapeutics
Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: cse:TTI
- Website: thiogenesis.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/thiogenesis-therapeutics-79815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.